Glycolipid markers of astrocytomas and oligodendrogliomas

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 12, 1999, Pages 1250-1262

  Yates, Allan J ^a,d   Comas, Theodore ^a   Scheithauer, Bernd W ^b   Burger, Peter C ^c   Pearl, Dennis K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Room 4166 Graves Hall ^*  (United States)

Author keywords

Astrocytoma; Brain tumor; Ganglioside; Glioma; Glycolipid; Oligodendroglioma; Pilocytic astrocytoma; Tumor marker

Indexed keywords

CERAMIDE TRIHEXOSIDE; GANGLIOSIDE GD 1A; GANGLIOTETRAOSYLCERAMIDE; GLYCOLIPID; GLYCOSYLTRANSFERASE; OLIGOSACCHARIDE; PARAGLOBOSIDE; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

EID: 0032801841     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199912000-00006     Document Type: Article

References (70)

1. Svennerholm L. Ganglioside designation. Adv Exp Med Biol 1980;125:11
2. Chester MA. IUPAC-IUB Joint Commission on biochemical nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Eur J Biochem 1998;257:293-98
3. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold S, Bullard DE. Clinicopathologic correlations in the Oligodendroglioma. Cancer 1987;59:1345-52
4. Alvord EC. Is necrosis helpful in the grading of gliomas? J Neuropathol Exp Neurol 1992;51:127-32
5. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997;79(7): 1381-93
6. Von Deimling A, Von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26
7. Louis DN. Clinicopatho-genetic subsets of glioblastoma multiforme: From both sides now. Brain Pathol 1996;6(3):223-24
8. Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999 (in press)
9. Ganju V, Jenkins RB, O'Fallon JR, et al. Prognostic factors in gliomas: A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer 1994;74: 920-27
10. Bigner SH, Rasheed BKA, Wiltshire R, McLendon RE. Morphologic and molecular genetic aspects of oligodendroglial neoplasms. Neuro-Oncology 1999;1:52-60
11. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54(1):91-95
12. Rasheed BKA, McLendon RE, Friedman HS, et al. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 1995;10(11):2243-46
13. Cairncross JG, Ueki K, Zlatesou MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90: 1473-79
14. Ekstrand AJ, Longo N, Hamid ML, et al. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994;9:2313-20
15. Sung CC, Pearl DK, Coons SW, Scheithauer BW, Johnson PC, Yates AJ. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 1994;74(11): 3010-22
16. Singh LPK, Pearl DK, Franklin TK, et al. Neutral glycolipid composition of primary human brain tumors. Mol Chem Neuropathol 1994;21:241-57
17. Yates AJ. Gangliosides in the nervous system during development and regeneration. Neurochem Path 1986;5:309-29
18. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 1989;24:548-57
19. Avossa D, Pfeiffer SE. Transient reversion of O4+ GalC -oligodendrocyte progenitor development in response to the phorbol ester TPA. J Neurosci Res 1993;34:113-28
20. Fok-Seang J, Miller RH. Distribution and differentiation of A2B5+ glial precursors in the developing rat spinal cord. J Neurosci Res 1994;37:219-35
21. Vanier MT, Holm M, Ohman R, Svennerholm L. Developmental profiles of gangliosides in human and rat brain. J Neurochem 1971;18:581-92
22. Chou DKH, Jungalwala FB. N-acetylglucosaminyltransferase regulates the expression of neolactoglycolipids including sulfoglucuronylglycolipids in the developing nervous system. J Biol Chem 1993;268:21727-33
23. Saqr HE, Lee M-C, Burkman AM, Yates AJ. Gangliosides have a bimodal effect on DNA synthesis in U-1242 MG human glioma cells. J Neurosci Res 1995;41:491-500
24. Bremer EG. Glycosphingolipids as effectors of growth and differentiation. In: Hoekstra D, ed. Cell lipids, current topics in membranes. San Diego: Academic Press, 1994;387-411
25. Yago K, Zenita K, Ginya H, et al. Expression of a-(1,3)-fucosyltransferases which synthesize sialyl Lex and sialyl Lea, the carbohydrate ligands for E- and P-selectins, in human malignant cell lines. Cancer Res 1993;53:5559-65
26. Merritt WD, Taylor BJ, Der-Minassian V, Reaman GH. Coexpression of Gd3 ganglioside with CD45RO in resting and activated human T lymphocytes. Cell Immunol 1996;173:131-48
27. Ortaldo JR, Mason AT, Longo DL, Beckwith M, Creekmore SP, McVicar DW. T cell activation via the disialoganglioside GD3: Analysis of signal transduction. J Leuukoc Biol 1996;60:533-39
28. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system, World Health Organization international histological classification of tumours. Second ed. New York: Springer-Verlag, 1993
29. Saito T, Hakomori S-I. Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res 1971;12:257-59
30. Svennerholm L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 1957;24:604-11
31. Miettinen T, Takki-Luukkainen IT. Use of butyl acetate in determination of sialic acid. Acta Chem Scand 1959;13:856-85
32. MacMillan VH, Wherrett JR. A modified procedure for the analysis of mixtures of tissue gangliosides. J Neurochem 1969;16:1621-24
33. Neskovic N, Sarlieve L, Nussbaum JL, Kostic D, Mandel P. Quantitative thin-layer chromatography of glycolipids in animal tissues. Clin Chim Acta 1972;38:147-53
34. Harris G, MacWilliam IC. Dipping technique for revealing sugars on paper chromatograms. Chemistry in Industry 1954;0:249
35. Bansal R, Stefansson K, Pfeiffer SE. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 1992;58:2221-29
36. Sung CC, Pearl DK, Coons SW, et al. Correlation of ganglioside patterns of primary brain tumors with survival. Cancer 1995;75: 851-59
37. Ishikawa Y, Gasa S, Minami R, Makita A. Characterization of neutral glycosphingolipids from fetal human brain: Evidence for stage-specific expression of the globo, ganglio, and neolacto series in the central nervous system. J Biochem 1987;101:1369-75
38. Holmes EH, Hakomori S-I, Ostrander GK Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonie adenocarcinoma and derived cell lines is due to activation of a normally unexpressed B1-3N-acetylglucosaminyltransferase. J Biol Chem 1987;262: 15649-58
39. Vierbuchen M, Schröder S, Larena A, Uhlenbruck G, Fischer R. Native and sialic acid masked Lewisa antigen reactivity in medullary thyroid carcinoma. Distinct tumour-associated and prognostic relevant antigens. Virchows Arch Int J Pathol 1994;424:205-11
40. Kitagawa H, Nakada H, Fukui S, et al. Novel gangliosides containing the sialyl-Lea structure from a human rectal adenocarcinoma. J Biol Chem 1993;268:26541-45
41. Buehler J, Qwan E, DeGregorio MW, Macher BA. Biosynthesis of glycosphingolipids by human myeloid leukemia cells. Biochemistry 1985;24:6978-84
42. Dasgupta S, Van Halbeek H, Hogan EL. Ganglio-N-tetraosylceramide (GAl) of bovine and human brain: Molecular characterization and presence in myelin. FEBS Lett 1992;301:141-44
43. Deshmukh DS, Vorbrodt AW, Lee PK, Bear WD, Kuizon S. Studies on the submicrosomal fractions of bovine oligodendroglia: Lipid composition and glycolipid biosynthesis. Neurochem Res 1988;13: 571-82
44. Amado M, Almeida R, Carneiro F, et al. A family of human B3-Galactosyltransferases. Characterization of four members of a UDP-galactose : B-N-acetyl-glucosamine/B-N-acetyl-galactosamine-B-1,3-galactosyltransfer ase family. J Biol Chem 1998;273:12770-78
45. Miyazaki H, Fukumoto S, Okada M, Hasegawa T, Furukawa K, Furukawa K. Expression cloning of rat cDNA encoding UDP-galactose:GD2 B1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1. J Biol Chem 1997;272:24794-99
46. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992;52:3213-19
47. Van Brocklyn J, Bremer EG, Yates AJ. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 Cells. J Neurochem 1993;61: 371-74
48. Yates AJ, Saqr HE, Van Brocklyn J. Ganglioside modulation of the PDGF receptor. A model for ganglioside function. J Neuro-Oncology 1994;24:65-73
49. Ekstrand AJ, Sugawa N, James CD, Collins VP. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 1992;89: 4309-13
50. Sugawa N, Ekstrand AJ, James CD, Collins VP. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 1990;87:8602-6
51. Jennemann R, Rodden A, Bauer BL, Mennel HD, Wiegandt H. Glycosphingolipids of human gliomas. Cancer Res 1990;50: 7444-49
52. Jennemann R, Mennel H-D, Bauer BL, Wiegandt H. Glycosphingolipid component profiles of human gliomas correlate with histological tumour types: Analysis of inter-individual and tumour-regional distribution. Acta Neurochir (Wien) 1994;126:170-78
53. El-Abbadi M, Seyfried T. Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol Chem Neuropathol 1994;21:273-85
54. Seyfried TN, El-Abbadi M, Ecsedy JA, Bai HW, Yohe HC. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J Neurochem 1996;66(5):2026-33
55. Li J, Pearl DK, Pfeiffer SE, Yates AJ. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors. J Neurosci Res 1994;39:148-58
56. Li J, Pearl DK, Pfeiffer SE, Yates AJ. Immunohistochemical staining of astrocytic tumors using antiglycolipid antibodies. J Neuropathol and Exp Neurol 1991;50:367
57. Macala LJ, Yohe HC. In situ accessibility of murine macrophage gangliosides. Glycobiology 1995; 5:67-75
58. von Hanwehr RI, Hofman FM, Taylor CR, Apuzzo MLJ. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg 1984;60:1138-47
59. Boker DK, Kalff R, Gulotta F, Weekes-Seifert S, Mohrer U. Mononuclear infiltrates in human intracranial tumors as a poor prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. Clin Neuropathol 1984;3:143-47
60. Phillips JP, Eremin O, Anderson JR. Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer 1982;45: 61-69
61. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (Berl) 1987;74:269-77
62. Rossi ML, Esiri MM, Jones NR, et al. Characterization of the mononuclear cell infiltrate and HLA-Dr expression in 19 oligodendrogliomas. Surg Neurol 1991;36:119-25
63. Hitchcock ER, Morris CS. Mononuclear cell infiltration in central portions of human astrocytomas. J Neurosurg 1988;68:432-37
64. Brooks WH, Markesbery WR, Gupta GD, Roszman TL. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978;4:219-24
65. Leenstra S, Das PK, Troost D, De Boer OJ, Bosch DA. Human malignant astrocytes express macrophage phenotype. J Neuroimmunol 1995;56:17-25
66. Almeida R, Amado M, David L, et al. A family of human B4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:B-N-acetylglucosamine B1,4-galactosyltransferases, B4Gal-T2 and B4Gal-T3. J Biol Chem 1997;272:31979-91
67. Hegi ME, Hausen AZ, Ruedi D, Malin G, Kleihues P. Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas. Int J Cancer 1997;73:57-63
68. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 1995;60:812-19
69. Shaper NL, Shaper JH, Bertness V, Chang H, Kirsch IR, Hollis GF. The human galactosyltransferase gene is on chromosome 9 at band p13. Somat Cell Mol Genet 1986;12:633-36
70. Cavenee WK, Bigner DD, Newcomb EW, Paulus W, Kleihues P. Diffuse astrocytomas, pathology and genetics. Tumours of the nervous system. Lyon: International Agency for Research on Cancer, 1997